| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in LQDA over the last quarter tilts toward selling: insiders offloaded a net 389,884 shares worth roughly $27.8M. In the past 30 days, 0 insiders bought and 9 sold.
On the other side, 9 insiders reduced their position over the period. LQDA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.13M | $733.82M | - | |
| CEO | 1.16M | $104.94M | -35,249 | |
| Dir | 701.5K | $63.29M | -78,596 | |
| Other | 606.0K | $54.67M | -14,738 | |
| Dir | 469.6K | $42.37M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Boyle Dana | Chief Accounting Officer | Sell | 445 | $30.58 | $13,608.10 | -0.2% | +99.9% | - | |
| Mar 2, 2026 | Kaseta Michael54 | CFO And COO | Sale+OE | 1,165 | $30.58 | $35,625.70 | -0.3% | +99.9% | - | |
| Jan 26, 2026 | Boyle Dana | Chief Accounting Officer | Sell | 1,580 | $41.65 | $65,807.00 | -0.9% | - | - | |
| Jan 26, 2026 | Adair Jason | Chief Business Officer | Sell | 688 | $41.65 | $28,655.20 | -0.3% | - | - | |
| Jan 12, 2026 | Adair Jason | Chief Business Officer | Sale+OE | 13,548 | $37.43 | $507,101.64 | -6.9% | +5.3% | - | |
| Jan 12, 2026 | Krepp Sarah | Chief Human Resource Officer | Sale+OE | 13,165 | $37.43 | $492,765.95 | -8.6% | +5.3% | - | |
| Jan 12, 2026 | Kaseta Michael54 | CFO And COO | Sale+OE | 36,932 | $37.43 | $1,382,364.76 | -9.5% | +5.3% | - | |
| Jan 12, 2026 | Moomaw Scott | Chief Commercial Officer | Sale+OE | 20,533 | $37.43 | $768,550.19 | -11.7% | +5.3% | - | |
| Jan 12, 2026 | Schundler Russell57 | General Counsel | Sale+OE | 27,289 | $37.43 | $1,021,427.27 | -4.5% | +5.3% | - | |
| Jan 12, 2026 | Jeffs Roger64 | Chief Executive Officer | Sale+OE | 66,610 | $37.43 | $2,493,212.30 | -6.0% | +5.3% | - |